RADIKO HOLDINGS CORP. Inactive Instrument
Radiko Holdings Corp. Share Price Canadian Securities Exchange
Equities
JUJU
CA75034R1029
Pharmaceuticals
| Sales 2018 | 107K 147K 8.9M | Sales 2019 | 5.18M 7.14M 433M | Capitalization | 6.17M 8.5M 515M |
|---|---|---|---|---|---|
| Net income 2018 | -4M -5.51M -334M | Net income 2019 | -10M -13.78M -835M | EV / Sales 2018 | 101 x |
| Net Debt 2018 | 259K 356K 21.59M | Net Debt 2019 | 1.98M 2.73M 165M | EV / Sales 2019 | 1.57 x |
| P/E ratio 2018 |
-1.5
x | P/E ratio 2019 |
-0.53
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.73% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16/18/16 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10/19/10 |
Scott Reeves
BRD | Director/Board Member | 55 | 01/17/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16/18/16 |
Scott Reeves
BRD | Director/Board Member | 55 | 01/17/01 |
Robert Yosaitis
BRD | Director/Board Member | - | 12/19/12 |
Radiko Holdings Corp., formerly International Cannabrands Inc., is a United States-based company. The Company is a pharmaceutical preparation manufacturer.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +34.00% | 704B | |
| +29.29% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +13.79% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
